Adrian Rawcliffe has been appointed managing partner and president of SR One Ltd., the venture arm of GlaxoSmithKline PLC (NYSE: GSK). The move becomes effective on June 1, with Rawcliffe succeeding Maxine Gowen, who was named senior vice president for a new GSK effort called the Centre of Excellence for External Drug Discovery.Rawcliffe has served in various positions with GSK, and has been in
People Briefs
the company’s Transactions & Ventures group since 2003.Mike Dolbec has joined The Ignite Group as a general partner, where he will focus on VC deals in the digital media, wire-free mobility, consumer electronics and data communications spaces.He previously was a general partner with Orange Ventures.Vaughn Kailan has joined MPM Capital as a general partner. He currently serves as chairman of ViaCell Inc., Elixer Pharmaceuticals Inc. and Ikaria Inc., and served and president and CEO of COR Therapeutics
Inc. from 1990 until 2002.Michael Darby has joined Paul Capital Partners as a San Francisco-based principal. He had served as a general partner of Battery Ventures until late 2002. Meritage Private Equity Funds, a Denver-based PE firm focused on the communications market, promoted Derek Pilling to vice president. He joined the firm in 2003.